| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 100,157 | 9,454 |
| Increase in cash, cash equivalents, and restricted cash | 75,248 | -6,653 |
| Cash and cash equivalents at beginning of period | 40,225 | - |
| Cash and cash equivalents at end of period | 115,473 | - |
CARLSMED, INC. (CARL)
CARLSMED, INC. (CARL)